3 results match your criteria: "Clinical Research Center For Metabolic Diseases Of Shanxi Medical University[Affiliation]"

Diagnostic performance of [18 F]FDOPA PET/CT and other tracers in pheochromocytoma: A meta-analysis.

Acad Radiol

September 2024

First Hospital of Shanxi Medical University, Clinical Research Center For Metabolic Diseases Of Shanxi Medical University, Taiyuan, Shanxi 030000, China (Y.R., J.Y.). Electronic address:

Article Synopsis
  • The study evaluates the effectiveness of various PET-CT tracers in diagnosing pheochromocytoma (PHEO), a type of tumor, by analyzing data from multiple medical research databases.
  • It includes a meta-analysis of 16 studies, finding that [18 F]FDOPA PET/CT has the highest sensitivity (97%) and specificity (94%) for PHEO detection, with an impressive diagnostic accuracy of 98.9%.
  • The research concludes that while PET/CT is generally effective for PHEO diagnosis, [18 F]FDOPA is the standout tracer among those evaluated, suggesting a need for further studies on other tracers.
View Article and Find Full Text PDF

Abnormal glucose metabolism is a common disease of the endocrine system. The effects of drugs on glucose metabolism have been reported frequently in recent years, and since abnormal glucose metabolism increases the risk of microvascular and macrovascular complications, metabolic disorders, and infection, clinicians need to pay close attention to these effects. A variety of common drugs can affect glucose metabolism and have different mechanisms of action.

View Article and Find Full Text PDF

The objective of this study is to conduct a bibliometric analysis of research trends in hyperprolactinemia from 2011 to 2023. This analysis aims to provide researchers with insights into the current hotspots and frontiers related to hyperprolactinemia. It is worth noting that there are currently no existing reports on bibliometric analyses of hyperprolactinemia.

View Article and Find Full Text PDF